title: Follow-up survey of women who have undergone a prevention of mother-to-child transmission program in a resource-poor setting in South Africa.
abstract: The aim of this study was to investigate the implementation of a prevention of mother-to-child transmission (PMTCT) program and to evaluate the uptake and adherence to single-dose nevirapine in a cohort sample that had undergone PMTCT in five public clinics in a resource-poor setting, Quakeni Local Service Area, O.R. Tambo District in the Eastern Cape, South Africa. Results indicated that 116 women (15.3% of the sample) were infected with HIV, 642 (84.7%) were uninfected, and 552 (42.1%) had an unknown HIV status. Almost all of the women had received information about HIV and HIV testing prenatally, but 552 (42%) had not been tested for HIV, and their HIV status was unknown. Only 66 (57%) of the HIV-infected pregnant women had been provided with nevirapine. It is recommended that the quality of HIV counseling be improved and the program of maternal self-medication with nevirapine tablets at onset of labor and maternal provision of nevirapine syrup to newborns be encouraged.
authors.affiliation: Health Systems Research Unit, Social Aspect of HIV/AIDS and Health, Human Sciences Research Council, Pretoria, South Africa.
authors.forename: Karl
authors.initials: K
authors.lastname: Peltzer
authors.forename: Thabang
authors.initials: T
authors.lastname: Mosala
authors.forename: Pelisa
authors.initials: P
authors.lastname: Dana
authors.forename: Henry
authors.initials: H
authors.lastname: Fomundam
mesh_terms: D001942:Breast Feeding; D015331:Cohort Studies; D003625:Data Collection; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000517:prevention & control*; D015276:Health Care Rationing; D006801:Humans; D007225:Infant Food; D007231:Infant, Newborn; D019829:Nevirapine / Q000008:administration & dosage*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D013019:South Africa
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine